The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 6, 1998, Pages 703-709

  Boswell, F J ^a   Andrews, J M ^a   Ashby, J P ^a   Fogarty, C ^a   Brenwald, N P ^a   Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; DOXYCYCLINE; ERYTHROMYCIN; KETOLIDE; LEVOFLOXACIN; ROXITHROMYCIN; TELITHROMYCIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES FRAGILIS; CHLAMYDIA; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SERUM; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; CHLAMYDIA; CHLAMYDIA INFECTIONS; CIPROFLOXACIN; HUMANS; KETOLIDES; LACTAMS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; SERUM BACTERICIDAL TEST;

EID: 0032416045     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.6.703     Document Type: Article

References (15)

1. Bryskier, A., Agouridas, C. & Chantot, J. F. (1997). Ketolides: new semisynthetic 14-membered-ring macrolides. In Expanding Indications for the New Macrolides, Azalides and Streptogramins (Zinner, S. H., Young, L. S., Acar, J. F. & Neu, H. C., Eds), pp. 39-50. Marcel Dekker Inc., New York.
2. Agouridas, C., Benedetti, Y., Denis, A., Le Martret, O. & Chantot, J. F. (1995). Ketolides: a new distinct class of macrolide antibacterials - synthesis and structural characteristics of RU 004. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F157, p. 140. American Society for Microbiology, Washington, DC.
3. Agouridas, C., Bonnefoy, A. & Chantot, J. F. (1995). In vitro antibacterial activity of RU 004, a novel ketolide highly active against respiratory pathogens. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F158, p. 140. American Society for Microbiology, Washington, DC.
4. Agouridas, C., Bonnfoy, A. & Chantot, J. F. (1994). Ketolides, a new semi-synthetic class of macrolide: In-vitro and in-vivo antibacterial activities. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract F168, p. 227. American Society for Microbiology, Washington, DC.
5. Langtry, H. D. & Brogden, R. N. (1997). Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients. Drugs 53, 973-1004.
6. Boswell, F. J., Andrews, J. M. & Wise, R. (1998). Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect. Journal of Antimicrobial Chemotherapy 41, 149-53.
7. Agouridas, C., Bonnefoy, A. & Chantot, J. F. (1995). Susceptibility testing conditions used and antibacterial activity of RU 004. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F169, p. 142. American Society for Microbiology, Washington, DC.
8. Working Party of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
9. Webberley, J. M., Matthews, R. S., Andrews, J. M. & Wise, R. (1987). Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis. European Journal of Clinical Microbiology 6, 587-9.
10. Kitzis, M. D., Goldstein, F. W., Bismuth, R., Miegi, M. & Acar, J. F. (1997). Comparative in vitro activity of HMR 3647, a new ketolide antibiotic against S. aureus (SA) and coagulase negative staphylococci (CNS). In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract F111, p. 165. American Society for Microbiology, Washington, DC.
11. Barry, A. L., Brown, S. D. & Fuchs, P. C. (1997). Antipneumococcal activity of a ketolide (HMR 3647) and seven related drugs in vitro. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. 1997. Abstract F107, p. 164. American Society for Microbiology, Washington, DC.
12. Agouridas, C., Bonnefoy, A. & Chantot, J. F. (1997). In vivo antibacterial activity of HMR 3647, a novel ketolide highly active against respiratory pathogens. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. 1997. Abstract F257, p. 189. American Society for Microbiology, Washington, DC.
13. Vesga, O. & Craig, W. A. (1997). Impact of macrolide resistance on the in vivo activity of a new ketolide HMR 3647 against S. pneumoniae (SP) and S. aureus (SA). In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. 1997. Abstract F259, p. 189. American Society for Microbiology, Washington, DC.
14. Ednie, L., Spangler, S., Jacobs, M. & Appelbaum, P. (1995). Anti-anaerobic activity of the ketolide RU 004 compared to 4 macrolides, 5 β-lactams, clindamycin and metronidazole. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F162, p. 141. American Society for Microbiology, Washington, DC.
15. Haider, F., Eb, F. & Orfila, J. (1995). Ketolides and chlamydia: in vitro evaluation of RU 004. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F165, p. 142. American Society for Microbiology, Washington, DC.